Europe's top psychedelic startups to watch, according to investors
Europe’s psychedelic sector is becoming increasingly mainstream, here are the top startups in the space, according to investors
Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Europe’s psychedelic sector is becoming increasingly mainstream, here are the top startups in the space, according to investors
Wall Street is growing increasingly bullish about the drugmaker's prospects.
Here's why OrthoPediatrics, Compass Pathways, and Nano-X Imaging look like great stocks.
Compass Pathways and other companies are investing in research on psychedelic drugs, hoping to treat conditions like PTSD, anxiety, and depression.
CEO says licensing amendment positions Optimi to be a “global leader in the safe supply of EU-GMP Psilocybin, MDMA, and other psychedelics”...